Anest. intenziv. Med. 2025;36(5):368-370 | DOI: 10.36290/aim.2025.061

Year 2025 in review - Paediatric anaesthesia and intensive careReview Article

Klabusayová E.1, 2*, Harazim H.1, 2*, Štourač P.1, 2
1 Klinika dětské anesteziologie a resuscitace, Fakultní nemocnice Brno a Lékařská fakulta Masarykovy Univerzity v Brně
2 Ústav simulační medicíny, Lékařská fakulta Masarykovy Univerzity v Brně *Oba autoři se podíleli na tvorbě článků stejným dílem

The article offers an overview of the most impactful publications of the past year. It highlights key findings and emerging trends with direct relevance to the anaesthesiology practice and care of critically ill children, helping readers quickly navigate the latest developments in the field. The selected studies are of high scientific quality, and their results can be directly applied in clinical practice. This article thus serves as a practical guide for physicians and healthcare professionals working in pediatric anaesthesiology and intensive care.

Keywords: anaesthesiology, intensive care, critical care, publication, 2025, paediatrics, paediatric patient, review.

Received: November 14, 2025; Revised: November 14, 2025; Accepted: December 9, 2025; Published: December 22, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Klabusayová E, Harazim H, Štourač P. Year 2025 in review - Paediatric anaesthesia and intensive care. Anest. intenziv. Med. 2025;36(5):368-370. doi: 10.36290/aim.2025.061.
Download citation

References

  1. Mensah-Osman E, Mukai Y, Wang A, Matuszczak M, Saldien V, Leibensperger H, et al. Sugammadex for Reversal of Neuromuscular Blockade in Neonates and Infants Less than 2 Years Old: Results from a Phase IV Randomized Clinical Trial. Anesth. 2025;143:300-12. doi: 10.1097/ALN.0000000000005535. Go to original source... Go to PubMed...
  2. Veyckemans F. Guidelines development and key recommendations. Euroanaesthesia 2025, Lisabon. Available at: https://esaic.meta-dcr.com/ea2025/crs/c-guidelines-development-and-key-recommendations.
  3. Miyasaka KW, Suzuki Y, Brown EN, Nagasaka Y. EEG-Guided Titration of Sevoflurane and Pediatric Anesthesia Emergence Delirium A Randomized Clinical Trial. JAMA Pediatr. 2025;179(7):704-712. doi:10.1001/jamapediatrics.2025.0517. Go to original source... Go to PubMed...
  4. Saynhalath R, Disma N, Taverner FJ, von Ungern-Sternberg BS, Andropoulos D, Ng AS, et al. Short-term Outcomes in Infants after General Anesthesia with Low-dose Sevoflurane/Dexmedetomidine/Remifentanil versus Standard-dose Sevoflurane (the TREX Trial). Anesthesiology. 2024;141(6):1075-1085. doi: 10.1097/ALN.0000000000005232. Go to original source... Go to PubMed...
  5. Silber JH, Rosenbaum PR, Reiter JG, Jain MSS, Hill AS, Hashemi S, et al. Exposure to Operative Anesthesia in Childhood and Subsequent Neurobehavioral Diagnoses: A Natural Experiment Using Appendectomy. Anesthesiology 2024;141:489-99. doi: 10.1097/ALN.0000000000005075. Go to original source... Go to PubMed...
  6. Albornoz AE, Navarro L, Mallen J, O'Halloran S, Denning S, Matava C, et al. A Quality Improvement Initiative to Improve Early Postoperative Pain Outcomes After Tonsillectomy in Children. Ped Anesth. 2025;0:1-9. doi: 10.1111/pan.70062. Go to original source... Go to PubMed...
  7. Penberthy KK, Dalesio NM. Perioperative management of pediatric patients with obstructive sleep apnea syndrome presenting for adenotonsillectomy. Curr Opin Anaesth. 2025;38(3):253-260. doi: 10.1097/ACO.0000000000001492. Go to original source... Go to PubMed...
  8. Djakow J, Turner NM, Skellett S, Buysseg CMP, Cardonah F, de Lucasi N, et al. European Resuscitation Council Guidelines 2025 Paediatric Life Support. Resuscitation. 2025;215(Suppl 1):110767. doi: 10.1016/S0300‑9572(25)00279‑5. Go to original source...
  9. Piktel JS, Wan X, Kouk S, Laurita KR, Wilson LD. Beneficial effect of calcium treatment for hyperkalemia is not due to "membrane stabilization". Crit Care Med. 2024;52(10):1499-508. doi: https://doi.org/10.1097/CCM.0000000000006376. Go to original source... Go to PubMed...
  10. Celebi Yamanoglu NG, Yamanoglu A. The effect of calcium gluconate in the treatment of hyperkalemia. Turk J Emerg Med. 2022;22(2):75-82. doi: https://doi.org/10.4103/2452-2473.342812guidelines 2021. Go to original source...
  11. Van de Voorde P, Maconochie I, Bingham R, de Lucas N, Martinez-Mejiasg A, Biarenth D, et al. European Resuscitation Council Guidelines 2021: Paediatric life support. Resuscitation. 2021;161:327‑387. doi: 10.1016/S0300‑9572(21)00068‑X. Go to original source...
  12. Peters MJ, Gould DW, Ray S, Thomas K, Chang I, Orzol M, et al. Conservative versus liberal oxygenation targets in critically ill children (Oxy-PICU): a UK multicentre, open, parallel-group, randomised clinical trial. Lancet. 2024;403(10424):355-364. doi: 10.1016/S0140-6736(23)01968-2. Go to original source... Go to PubMed...
  13. Ray S, Wiegand M, Gould DW, Harrison DA, Mouncey PR, Peters MJ, et al. Severity of Impaired Oxygenation and Conservative Oxygenation Targets in Mechanically Ventilated Children: A Post Hoc Subgroup Analysis of the Oxy-PICU Trial of Conservative Oxygenation. Pediatr Crit Care Med. 2025;26(4):e492-e497. doi: 10.1097/PCC.0000000000003686. Go to original source... Go to PubMed...
  14. LaRovere KL, Asaro LA, Coughlin-Wells K, Nadkarni VM, Agus MSD; Heart and Lung Failure - Pediatric Insulin Titration (HALF-PINT) Study Investigators. Blood Glucose Range for Hyperglycemic PICU Children With Primary Neurologic Diagnoses: Analysis of the Heart and Lung Failure-Pediatric Insulin Titration (HALF-PINT) Trial. Pediatr Crit Care Med. 2025;26(4):e432-e446. doi: 10.1097/PCC.0000000000003689. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.